Sunesis
researches, develops and commercializes oncology therapeutics for the treatment of solid and hematologic cancers... Read moreSunesis
researches, develops and commercializes oncology therapeutics for the treatment of solid and hematologic cancers... Read more
1998
PrivateMerged with Viracta Therapeutics, Inc.
News
Aug 09, 2022
Associated Press News
Sunesis: Sunesis: Q2 Earnings Snapshot
May 10, 2022
Associated Press News
Sunesis: Sunesis: Q1 Earnings Snapshot
Feb 25, 2021
socalTECH
Sunesis: Viracta Therapeutics Goes Public Via Reverse Merger, Gets $65M
Feb 24, 2021
BioSpace
Sunesis: Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement
Feb 24, 2021
Seeking Alpha
Sunesis: Sunesis Pharma continues momentum after Q4 earnings beat consensus
Feb 23, 2021
InvestorPlace
Sunesis: SNSS Stock: Why Sunesis Pharmaceuticals Is Soaring Today
Feb 16, 2021
Benzinga
Sunesis: Sunesis Pharma Climbs After Viracta Poised To Nab US Patent For Nanatinostat/Valganciclovir Regime
Dec 30, 2020
MarketScreener
Sunesis: SUNESIS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sunesis Pharmaceuticals, Inc. - SNSS
Dec 12, 2020
MarketScreener
Sunesis: INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm - SNSS, WORK, WDR, ANH
Dec 07, 2020
Seeking Alpha
Sunesis: Sunesis rises 1.9% after Viracta sees registration trial in H1 for lymphoma regimen
Sunesis Competitors
1
2
3
4
5
6
7
8
9
10